DE69432470D1 - Dna kodierend für prostaglandin rezeptor ip - Google Patents

Dna kodierend für prostaglandin rezeptor ip

Info

Publication number
DE69432470D1
DE69432470D1 DE69432470T DE69432470T DE69432470D1 DE 69432470 D1 DE69432470 D1 DE 69432470D1 DE 69432470 T DE69432470 T DE 69432470T DE 69432470 T DE69432470 T DE 69432470T DE 69432470 D1 DE69432470 D1 DE 69432470D1
Authority
DE
Germany
Prior art keywords
prostaglandin receptor
receptor
dna coding
host cells
dna encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69432470T
Other languages
English (en)
Other versions
DE69432470T2 (de
Inventor
Mark Abramovitz
Yves Boie
Richard Grygorczyk
Kathleen Metters
Thomas H Rushmore
Deborah M Slipetz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Canada Inc
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22461361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69432470(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Application granted granted Critical
Publication of DE69432470D1 publication Critical patent/DE69432470D1/de
Publication of DE69432470T2 publication Critical patent/DE69432470T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69432470T 1993-10-06 1994-10-03 Dna kodierend für prostaglandin rezeptor ip Expired - Lifetime DE69432470T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/134,012 US5516652A (en) 1993-10-06 1993-10-06 DNA encoding prostaglandin receptor IP
PCT/CA1994/000548 WO1995009872A1 (en) 1993-10-06 1994-10-03 Dna encoding prostaglandin receptor ip

Publications (2)

Publication Number Publication Date
DE69432470D1 true DE69432470D1 (de) 2003-05-15
DE69432470T2 DE69432470T2 (de) 2004-01-29

Family

ID=22461361

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69432470T Expired - Lifetime DE69432470T2 (de) 1993-10-06 1994-10-03 Dna kodierend für prostaglandin rezeptor ip

Country Status (8)

Country Link
US (3) US5516652A (de)
EP (1) EP0722462B1 (de)
JP (1) JP3029125B2 (de)
AT (1) ATE236932T1 (de)
CA (1) CA2173595C (de)
DE (1) DE69432470T2 (de)
ES (1) ES2192561T3 (de)
WO (1) WO1995009872A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3692536B2 (ja) * 1994-02-10 2005-09-07 小野薬品工業株式会社 プロスタグランジンｉ２受容体
US6395878B1 (en) * 1994-05-05 2002-05-28 Allergan Sales, Inc. Nucleic acid encoding a human EP prostaglandin receptor
EP0812353A2 (de) 1995-01-26 1997-12-17 Merck Frosst Canada Inc. Prostaglandin rezeptor dp
ATE281432T1 (de) 1999-03-05 2004-11-15 Univ Duke C-16 ungesätigte fp-selektive prostaglandin analoge
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020013294A1 (en) * 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US6673760B1 (en) * 2000-06-29 2004-01-06 Ecolab Inc. Rinse agent composition and method for rinsing a substrate surface
AU2003236673A1 (en) * 2002-01-22 2003-09-02 Bristol-Myers Squibb Company G protein-coupled receptor variants
DE10229872A1 (de) * 2002-07-03 2004-01-29 Curevac Gmbh Immunstimulation durch chemisch modifizierte RNA
WO2004071508A1 (en) * 2003-02-14 2004-08-26 Medical Research Council Ip receptor antagonists for the treatment of pathological uterine conditions
DE102006035618A1 (de) * 2006-07-31 2008-02-07 Curevac Gmbh Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz
WO2008014979A2 (en) 2006-07-31 2008-02-07 Curevac Gmbh NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
WO2009030254A1 (en) 2007-09-04 2009-03-12 Curevac Gmbh Complexes of rna and cationic peptides for transfection and for immunostimulation
HUE025027T2 (en) 2008-01-31 2016-07-28 Curevac Gmbh (NuGiXmGnNv) nucleic acids and derivatives of the formula as immunostimulants / adjuvants
WO2010037408A1 (en) 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110053829A1 (en) 2009-09-03 2011-03-03 Curevac Gmbh Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
WO2011159904A1 (en) * 2010-06-17 2011-12-22 The Trustees Of The University Of Pennsylvania Methods for predicting cellular signaling responses to combinatorial stimuli
SG186989A1 (en) 2010-07-14 2013-02-28 Novartis Ag Ip receptor agonist heterocyclic compounds
MX336839B (es) 2010-07-30 2016-02-03 Curevac Gmbh Formacion de complejos de acidos nucleicos con componentes cationicos entrelazados por disulfuro para transfeccion e inmunoestimulacion.
AR089698A1 (es) 2012-01-13 2014-09-10 Novartis Ag Compuestos heterociclicos antagonistas del receptor ip
WO2013113326A1 (en) 2012-01-31 2013-08-08 Curevac Gmbh Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
US9604981B2 (en) 2013-02-13 2017-03-28 Novartis Ag IP receptor agonist heterocyclic compounds
SG11201510746WA (en) 2013-08-21 2016-03-30 Curevac Ag Respiratory syncytial virus (rsv) vaccine
EP3129050A2 (de) 2014-04-01 2017-02-15 CureVac AG Polymerträger-cargo-komplex zur verwendung als immunstimulierendes mittel oder als ein adjuvans

Also Published As

Publication number Publication date
JPH09503213A (ja) 1997-03-31
EP0722462A1 (de) 1996-07-24
US5516652A (en) 1996-05-14
EP0722462B1 (de) 2003-04-09
ATE236932T1 (de) 2003-04-15
CA2173595C (en) 2001-06-12
US6365360B1 (en) 2002-04-02
US5728808A (en) 1998-03-17
DE69432470T2 (de) 2004-01-29
JP3029125B2 (ja) 2000-04-04
WO1995009872A1 (en) 1995-04-13
ES2192561T3 (es) 2003-10-16
CA2173595A1 (en) 1995-04-13

Similar Documents

Publication Publication Date Title
DE69432470D1 (de) Dna kodierend für prostaglandin rezeptor ip
ATE170532T1 (de) Prostaglandin rezeptor fp und kodierende dns
CA2170509A1 (en) Dna encoding prostaglandin receptor ep2
ES2153037T3 (es) Lacasas purificadas de scytalidium y acidos nucleicos que las codifican.
ATE157398T1 (de) Prostaglandinrezeptor ep1 kodierende dna
WO1996023066A3 (en) Prostaglandin receptor, dp
PT765394E (pt) Lacases myceliophthora purificadas e acidos nucleicos que as codificam
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
DE3789273D1 (de) Kodierungssystem zur Reduktion der Redundanz.
ATE389666T1 (de) Hohe expressionsrate von proteinen
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
DE69939982D1 (de) B7l-1 moleküle
DE69426033D1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
ATE172471T1 (de) Prostaglandin rezeptor ep3 und kodierende dns
DE69535316D1 (de) Als lerk6 bezeichnetes cytokin
AR001014A1 (es) Una molecula de dna aislada que codifica daunorubicina 14-hidroxilasa, dicha daunorubicina 14-hidroxilasa, procedimiento para producir dicho dna,vector que comprende dicho dna, celula huesped que contiene dicho vector, procedimiento para producir doxorubicina mediante dicha celula
DE69939587D1 (en) Semaphorin polypeptide
NO905545D0 (no) Renset ubiquitinhydrolase, dna-sekvenser som koder for samme, samt anvendelse for isolering av polypeptider.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK FROSST CANADA LTD., KIRKLAND, QUEBEC, CA